The mechanism may be related to the down-regulation of LXRα/SREBP-1c/FAS/ACC and SREBP2/HMGCR signaling pathways, which may provide a theoretical basis for the prevention and treatment of hyperlipidemia. Here, SREBF1 is linked to hyperlipidemia.